SAN FRANCISCO, July 3 /PRNewswire-USNewswire/ -- Tomorrow, Corey Reich, an ALS patient from Piedmont, California, will attend both the San Francisco Giants and Los Angeles Angels of Anaheim baseball games this July 4th as a representative of the ALS Therapy Development Institute (ALS TDI). Corey will attend both baseball games to raise awareness of amyotrophic lateral scleroses (ALS, Lou Gehrig's disease) a neurodegenerative disease of which he suffers and for which there is no known cause or cure.
"My hope is that my presence at both games will help to put a new face on this disease by providing a personal connection to ALS," said Corey. "Although it is an orphan disease, I hope to bring larger public awareness and increased funding for research, which could speed up the discovery of therapies for people like me living with ALS."
Corey was diagnosed in July of 2007, but he had shown symptoms for several years prior. After his diagnosis, he returned to Middlebury College and graduated with honors in May of 2008. He currently is the assistant tennis coach for the Piedmont High School Men's and Women's Tennis Teams. Corey and his family have supported ALS TDI for the past 18 months and have raised more than $700,000 in that time. Fundraising events organized by "Corey's Crusaders" have included a cocktail party in the Vancouver, Washington area, a running race in Boise, a bake sale in Oakland, a dinner and dance also in Oakland, and another dinner and dance in Bronxville, New York. ALS TDI, based in Cambridge, Massachusetts, is a 501c3 nonprofit charitable organization and the largest research center dedicated solely to the development of therapeutics for this debilitating disease.
Corey's attendance at the Giants' and Angels' games coincides with the culmination of Major League Baseball's "4ALS Awareness" campaign. MLB is working with four leading organizations -- The ALS Association, AL
Page: 1 2 3 Related biology technology :1
|SOURCE ALS Therapy Development Foundation|
Copyright©2009 PR Newswire.
All rights reserved
. Encision Enters Into Sales Representation Agreement With Caldera Medical2
. Air Transport Association Applauds House of Representatives on Decision to Withhold Biometric Collection Funding3
. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States4
. CMR Institute: Education Key to Physician/Representative Relationship5
. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives6
. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative7
. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer8
. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India9
. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer10
. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB11
. Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia